Search Details

Word: caskey (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...consumer loans at its usual rock-bottom prices, "the cost of banking services would decline, and consumers would say, 'This is great.'" Wal-Mart would also be in a good position to reach the 10 million households in the U.S. that don't use a bank account, says John Caskey, a professor of economics at Swarthmore and expert on the "unbanked." The company has already punctured the high cost of check cashing, which hits the unbanked hardest, by offering the service in its stores. Caskey says that with the right mix of low-cost services--bill payment, money orders, check...

Author: /time Magazine | Title: Wal-Mart's Bank Shot | 4/17/2006 | See Source »

...estimated 200,000 DNA profiles are run each year by states trying to document child-support or welfare payments, folks with paternity issues rarely have the wherewithal to order up a test on their own. About five years ago, however, that started to change. It was then that Caroline Caskey, 32, a French-literature major turned business student, thought to combine cutting-edge DNA analysis with old-fashioned, hawk-the-product marketing. A few years earlier, a lab headed by her father Thomas Caskey patented something called the "short tandem repeat," a shortcut method of sampling DNA. Caskey...

Author: /time Magazine | Title: Genes and Money | 4/12/1999 | See Source »

...such niceties carry little weight for people desperate to establish something as consequential as paternity, and Caskey plans to keep cashing in on that need. Identigene is preparing to offer an even cheaper, $150 test that will profile newborns' DNA to reassure anxious parents that they're leaving the hospital with their own child. "It's potentially a much bigger market than paternity testing," says Caskey. And a bigger payoff...

Author: /time Magazine | Title: Genes and Money | 4/12/1999 | See Source »

...technology and gene discoveries to develop an array of novel drugs. "Now that we have an increasing ability to identify and sequence genes, there is no doubt that there will be an improvement in the way we go about drug development," says Dr. C. Thomas Caskey, senior vice president of basic research at Merck, in Whitehouse Station, New Jersey...

Author: /time Magazine | Title: KEYS TO THE KINGDOM | 9/18/1996 | See Source »

...example, explains Caskey, researchers know that there are at least three or four forms of Alzheimer's disease, each of which may be caused by a different defective gene. "If I develop a drug for gene A," he says, "it may not have any influence on a patient who has a defect on gene C. So it's easy to understand how genomics research would be critical to the development of very precise and effective drugs...

Author: /time Magazine | Title: KEYS TO THE KINGDOM | 9/18/1996 | See Source »

| 1 | 2 | 3 | 4 | 5 | 6 | Next